Can Haematological Parameters Discriminate COVID-19 from Influenza?
Sahar Gnaba(Hôpital Foch), Marc Vasse(Hôpital Foch), Frédérique Delcominette(Hôpital Foch), Florence Habarou(Hôpital Foch), Tiffany Pascreau(Inserm), Émilie Jolly(Hôpital Foch), Aurélie Védrenne(Hôpital Foch), Dmitry Sukhachev, Félix Ackermann(Hôpital Foch), Éric Farfour(European Foundation for Clinical Nanomedicine), Elena Sukhacheva
Cited by 0
Related Papers
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
|Annals of the Rheumatic Diseases|2012|207
International clinical guidelines for the management of phosphomannomutase 2‐congenital disorders of glycosylation: Diagnosis, treatment and follow up
|Journal of Inherited Metabolic Disease|2019|149
Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus
|Arthritis & Rheumatology|2015|140